Scrip Podcasts

Norstella
Norstella

Scrip delivers expert-driven audio insight on biopharma — from R&D, commercial strategy and deal activity to coverage of major industry events. Every Monday, Ian Haydock presents Quick Listen: Five Must-Know Things, a weekly roundup of top industry stories. Joseph Haas hosts a quarterly deep-dive into dealmaking with guests from leading companies, law firms and investment firms. Visit https://insights.citeline.com/scrip to sign up. For any podcast feedback or queries, you can now reach us at podcasts@norstella.com.

  1. 1d ago

    Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 27, 2026

    本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月24日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 诺和诺德在肥胖症治疗领域起诉礼来；特朗普针对仿制药采取新的关税措施；诺华CEO称赞日本、抨击德国的定价政策；制药行业会迎来“稀土时刻”吗？；以及欧洲生物技术行业正处于十字路口。 Story/video links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2BIDCWDH5BAVLJ2QXPT6EL5U44/ 向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

  2. 1d ago

    Scrip's Five Must-Know Things - July 27, 2026

    Audio roundup of selected biopharma industry content from Scrip over the business week ended July 24, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time—Novo Nordisk sues Lilly in obesity battle; Trump takes new tariff action on generics; Novartis CEO praises Japan, blasts Germany on pricing; could pharma have a rare earth moment?; and European biotech at a crossroads.  Story/video links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2BIDCWDH5BAVLJ2QXPT6EL5U44/ This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

    Scrip's Five Must-Know Things - July 27, 2026

  3. 5d ago

    European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast

    This Scrip video podcast brings together three European biotech leaders to discuss the challenges facing the sector, and what measures are needed to stop it falling behind the US and China and to create the next generation of European biotech champions.

    European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast

  4. Jul 21

    Scrip's Five Must-Know Things - July 21, 2026

    Audio roundup of selected biopharma industry content from Scrip over the business week ended July 17, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time—J&J ups guidance; Gilead’s acquisition strategies; Bayer breakup rumors; Biogen’s Alzheimer’s results; and an interview with Lilly’s blood test pioneer.  Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-OBTX6Q73CNCKVDV6GDYG4YM7SI/ This and all our other podcasts are available on the Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

  5. Jul 21

    Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 21, 2026

    本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月17日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 强生上调业绩预期；吉利德的收购策略；拜耳拆分传闻；百健的阿尔茨海默病研究结果；以及对礼来血液检测先驱的专访。 向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

    Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 21, 2026

  6. Jul 20

    Alzheimer's AAIC Video Interview: Denali Therapeutics

    Denali CEO Ryan Watts talks about the company's TransportVehicle platform and how it can open up delivery of a wide range of drug cargoes into the brain. Its first approved therapy is Avlayah for Hunter Syndrome, with tau and beta-amyloid targeting assets for Alzheimer's in development.

    Alzheimer's AAIC Video Interview: Denali Therapeutics

  7. Jul 17

    Eisai Video Interview AT AAIC Alzheimer's Conference, July 15

    Eisai's Michael Irizarry talks to Scrip about broadening Leqembi's use with its subcutaneous version, its ongoing Phase III in treating patients before dementia symptoms appear and news from a Phase II study of it tau-targeting asset, etalanetug.

    Eisai Video Interview AT AAIC Alzheimer's Conference, July 15

  8. Jul 16

    Scrip Deals Podcast, July 2026, with Dr. Bruce Leuchter

    On the July 2026 edition of the Scrip Deals Podcast, Scrip Senior Writer Joseph Haas and Bruce Leuchter, CEO of Neurvati Biosciences and GRIN Therapeutics, discussed the recent trend of biopharma M&A deals valued at $1bn or greater closing quickly. Recent research showed that closing time for such deals is less than half of how long it took to close a billion-dollar acquisition during the span on 2023-2025.. Leuchter offered some insights on why this might be. Haas and Leuchter also discussed M&A activity during the just-ended second quarter of 2026.

    Scrip Deals Podcast, July 2026, with Dr. Bruce Leuchter
See All (15)

About

Scrip delivers expert-driven audio insight on biopharma — from R&D, commercial strategy and deal activity to coverage of major industry events. Every Monday, Ian Haydock presents Quick Listen: Five Must-Know Things, a weekly roundup of top industry stories. Joseph Haas hosts a quarterly deep-dive into dealmaking with guests from leading companies, law firms and investment firms. Visit https://insights.citeline.com/scrip to sign up. For any podcast feedback or queries, you can now reach us at podcasts@norstella.com.

Information

  • Channel
    Norstella
  • Creator
    Norstella
  • Years Active
    2026
  • Episodes
    15
  • Copyright
    © All rights reserved
  • Show Website
    Scrip Podcasts

More From Norstella